Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07386925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pelargonium Graveolens Essential Oil as a Pulpotomy Agent in Primary Teeth

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Study sites: 1 to 2 · Start date changed from estimate of Feb 2026 to Feb 5, 2026 · Eligibility criteria expanded, about 12 words · 1 more Show 4 more changesShow less
    • Study sites: 1 to 2
    • Start date changed from estimate of Feb 2026 to Feb 5, 2026
    • Eligibility criteria expanded, about 12 words
    • Study description revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The success of pulpotomy in primary teeth is critical for preserving function and arch integrity in children and depends largely on the biological properties of the medicament used. Given the limitations of mineral trioxide aggregate, Pelargonium graveolens essential oil has emerged as a potential alternative; however, its clinical performance as a pulpotomy agent remains insufficiently investigated.
Trial Details
NCT Number NCT07386925
Lead Sponsor Tanta University
Conditions Pulpitis - Reversible, Pulpotomies on Primary Molars
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov